Obesity With Diabetes
Metabolic·MeSH: Obesity
Prevalence
42000.0 / 100K
Incidence
2000.0 / 100K/yr
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| KAI-9531 | ENANTA PHARMACEUTICALS INC (ENTA) |
Frequently asked questions
How many drugs are in development for Obesity With Diabetes?
BioSniper tracks 1 drug in development for Obesity With Diabetes across 1 company.
How many clinical trials target Obesity With Diabetes?
There are 1 clinical trial targeting Obesity With Diabetes tracked by BioSniper.
What is the prevalence of Obesity With Diabetes?
The estimated prevalence of Obesity With Diabetes is approximately 42000.0 per 100,000 population.
Deep-dive into Obesity With Diabetes
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis